Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGSWW) Equity Ratio (2020 - 2025)

GeneDx Holdings has reported Equity Ratio over the past 6 years, most recently at 0.59 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.59 for Q4 2025, up 0.63% from a year ago — trailing twelve months through Dec 2025 was 0.59 (up 0.63% YoY), and the annual figure for FY2025 was 0.59, up 0.63%.
  • Equity Ratio for Q4 2025 was 0.59 at GeneDx Holdings, down from 0.59 in the prior quarter.
  • Over the last five years, Equity Ratio for WGSWW hit a ceiling of 0.7 in Q4 2021 and a floor of 3.23 in Q2 2021.
  • Median Equity Ratio over the past 5 years was 0.59 (2025), compared with a mean of 0.25.
  • Biggest five-year swings in Equity Ratio: surged 240.87% in 2021 and later decreased 26.22% in 2022.
  • GeneDx Holdings' Equity Ratio stood at 0.7 in 2021, then decreased by 26.22% to 0.52 in 2022, then increased by 5.37% to 0.54 in 2023, then increased by 7.4% to 0.58 in 2024, then rose by 0.63% to 0.59 in 2025.
  • The last three reported values for Equity Ratio were 0.59 (Q4 2025), 0.59 (Q3 2025), and 0.6 (Q2 2025) per Business Quant data.